12:30:16 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



Q:PODD - INSULET CORPORATION - https://www.insulet.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PODD - Q5.0165.64·166.955.0166.19+2.021.2636.2105,11311,822163.32  168.43  162.99335.91  125.8217:32:51Apr 0315 min RT 2¢

Recent Trades - Last 10 of 11822
Time ETExPriceChangeVolume
17:32:51Q166.192.0286,300
17:05:36Q166.192.023,603
16:50:57Q167.963.793
16:50:37Q171.677.501
16:47:01Q165.571.402
16:38:47Q163.50-0.67100
16:20:00Q166.192.02137
16:06:39Q166.192.0216
16:02:29Q166.192.0236
16:02:28Q166.192.029

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-03 06:00U:PODDNews ReleaseInsulet to Announce First Quarter 2024 Financial Results on May 9, 2024
2024-03-20 06:00U:PODDNews ReleaseInsulet Appoints Ana Maria Chadwick as Chief Financial Officer
2024-03-08 06:00U:PODDNews ReleaseInsulet's Randomized Controlled Trial (OP5-003) Demonstrates Omnipod(TM) 5 Automated Insulin Delivery System is Superior to Pump Therapy
2024-03-05 06:00U:PODDNews ReleaseInsulet to Present Results from First Omnipod(TM) 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
2024-02-22 16:07U:PODDNews ReleaseInsulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)
2024-02-13 16:01U:PODDNews ReleaseInsulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference
2024-02-07 06:00U:PODDNews ReleaseInsulet Announces CE Mark Approval of Omnipod ‚ ® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
2024-01-18 16:01U:PODDNews ReleaseInsulet Announces Changes to Board of Directors with Retirements and New Appointments
2024-01-11 06:00U:PODDNews ReleaseInsulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
2023-11-28 06:00U:PODDNews ReleaseInsulet to Present at Upcoming Investor Conferences
2023-11-01 06:00U:PODDNews ReleaseInsulet Spotlights Diabetes Awareness on World Diabetes Day and Throughout November
2023-10-23 06:00U:PODDNews ReleaseInsulet Announces FDA 510(k) Clearance of the Omnipod ‚ ® 5 App for iPhone
2023-10-03 16:15U:PODDNews ReleaseInsulet Announces CFO Transition
2023-10-02 06:00U:PODDNews ReleaseInsulet to Present Extended Real-World Evidence and Best Practices for Optimizing Care with Omnipod ‚ ® 5
2023-09-28 06:00U:PODDNews ReleaseInsulet to Announce Third Quarter 2023 Financial Results on November 2, 2023
2023-08-28 06:00U:PODDNews ReleaseInsulet Announces Full Market Release of Omnipod ‚ ® 5 Automated Insulin Delivery System in Germany
2023-08-24 06:00U:PODDNews ReleaseInsulet to Present at Upcoming Investor Conferences
2023-08-08 16:01U:PODDNews ReleaseInsulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1)
2023-07-05 06:00U:PODDNews ReleaseInsulet to Announce Second Quarter 2023 Financial Results on August 8, 2023
2023-06-22 06:00U:PODDNews ReleaseInsulet Celebrates One Year of Omnipod ‚ ® 5 at the American Diabetes Association 83rd Scientific Sessions